Single Dose Mass Balance Study With C14 - Labeled AAI101 in Healthy Male Volunteers

Summary

This is an open-label, single dose, pharmacokinetic (PK) study conducted at 1 study center in the United States (USA). This study will evaluate the absorption, distribution, metabolism, and elimination (ADME), mass balance, safety, and tolerability of a single dose of intravenously administered 14C-AAI101.

Timeline

Start

2018-11-27

Primary completion

2018-12-05

Completion

2019-01-31

Drugs

Indications

No indication recorded.